COVID-19 was initially identified in an outbreak of viral pneumonia in Wuhan in December 2019, and has now been recognized in 77 countries with over 90,000 laboratory-confirmed cases and over 3,000 deaths as of 3 March 2020 [1] The epidemiology of COVID-19 has recently become clearer as incident cases continue to rise and researchers refine estimates of the severity, transmissibility, and populations affected Based on available data, COVID-19 is efficiently transmitted in the community, and the proportion of infections leading to severe illness is particularly high among adults ≥50 years of age and among individuals with comorbid health conditions Although rare, severe cases have also been reported among younger individuals Thus far, the estimated basic reproductive number (R0) of COVID-19 is higher than that of influenza [2], as is the case fatality risk for adults and older individuals An estimated 80% of COVID-19 cases are mild [1] This is not a glass half full statistic, as 20% of infections result in clinically severe cases that have the potential to overwhelm already overburdened health facilities Given the lack of vaccines and effective antivirals, nonpharmaceutical interventions (NPIs) are the most effective available interventions for local and global control and mitigation of COVID-19 To date, measures aimed at slowing introduction of infection globally have included travel restrictions, isolation of confirmed cases, and quarantine of exposed persons In the United States, NPIs have reduced the number of infected persons entering the country, but recent outbreaks in multiple US states make it clear that these measures have delayed but not prevented community transmission In 2009, NPIs were able to delay large epidemic waves of pandemic influenza A(H1N1)pdm09 in some locations until after the summer, since influenza transmission tends to be reduced by higher temperatures and humidity It is unclear whether COVID-19 transmission will be heavily affected by seasonal weather variation, given that transmission is now occurring in multiple tropical and sub-tropical locations
[1]
N. E. Babady,et al.
Responding to the Challenges of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
,
2020,
The Journal of molecular diagnostics : JMD.
[2]
A. Amigoni,et al.
Testing for Novel Coronavirus Antibodies: A Necessary Adjunct
,
2020,
The Journal of infectious diseases.
[3]
J. Wong,et al.
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures
,
2020,
Emerging infectious diseases.
[4]
J. Wong,et al.
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Social Distancing Measures
,
2020,
Emerging infectious diseases.
[5]
E. Gentile,et al.
A Preliminary Evaluation of the Public Risk Perception Related to the COVID-19 Health Emergency in Italy
,
2020,
International journal of environmental research and public health.
[6]
David M. Hartley,et al.
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices
,
2020,
Biology of Blood and Marrow Transplantation.
[7]
Arnab Chanda,et al.
Effect of weather on COVID-19 spread in the US: A prediction model for India in 2020
,
2020,
Science of The Total Environment.
[8]
T. Hollingsworth,et al.
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
,
2020,
The Lancet.
[9]
Jing Zhao,et al.
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
,
2020,
The New England journal of medicine.
[10]
Neil M. Ferguson,et al.
The effect of public health measures on the 1918 influenza pandemic in U.S. cities
,
2007,
Proceedings of the National Academy of Sciences.
[11]
Stefan Ma,et al.
Societal Learning in Epidemics: Intervention Effectiveness during the 2003 SARS Outbreak in Singapore
,
2006,
PloS one.